Showing results (911-920 of 2,915) with videos related to
Sort By:
Pageof 292
Cancer Gene Therapy|July 6, 2022
Application of ATAC-seq in tumor-specific T cell exhaustionChufeng Chen, Jiaying Liu, Yidong Chen, et al.Cancer Gene Therapy|June 28, 2022
SIX3 function in cancer: progression and comprehensive analysisTian-Liang Ma, Peng Zhu, Jing-Xian Chen, et al.Cancer Gene Therapy|January 4, 2023
LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206 /SLC7A11 axis in osteosarcoma cellsLuoying Li, Yifan Zhang, Yan Gao, et al.Cancer Gene Therapy|January 12, 2023
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinomaRahul Arora, Logan Haynes, Mehul Kumar, et al.Cancer Gene Therapy|December 27, 2022
HPV status represents dominant trait driving delineation of survival-associated gene co-expression networks in head and neck cancerAhmed M Mehdi, Chenhao Zhou, Gavin Turrell, et al.Cancer Gene Therapy|January 6, 2021
γ-Glutamylcyclotransferase, a novel regulator of HIF-1α expression, triggers aerobic glycolysisKeiko Taniguchi, Susumu Kageyama, Chiami Moyama, et al.Cancer Gene Therapy|May 20, 2022
Ixovex-1, a novel oncolytic E1B-mutated adenovirusMohiemen Anwar, Maja-Louise Arendt, Mohanraj Ramachandran, et al.Cancer Gene Therapy|October 7, 2017
Role of autophagy in oncolytic herpes simplex virus type 1-induced cell death in squamous cell carcinoma cellsY Furukawa, A Takasu, Y YuraCancer Gene Therapy|July 1, 1997
The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.Cancer Gene Therapy|July 1, 1997
The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosisR E Buller, A Sood, C Fullenkamp, et al.Pageof 292